Oracle Partners Lp - Insider Trading Tracker

Abeona Therapeutics Inc.

US ˙ NasdaqCM ˙ US00289Y2063

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Oracle Partners Lp. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Veja os Insiders com Maior Classificação

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Oracle Partners Lp reportou posses ou negociações nas seguintes empresas:

Ativo	Título	Últimas Posições Reportadas
US:MOTS / Motus GI Holdings, Inc.		0
US:BIOL / BIOLASE, Inc.	10% Owner	0
US:VRML / Vermillion, Inc.	10% Owner	0
US:SLNO / Soleno Therapeutics, Inc.	10% Owner	655,000
US:HNSN / Hansen Medical, Inc.	10% Owner	0
US:ACCP /	10% Owner	247,651

Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Oracle Partners Lp. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas ABEO / Abeona Therapeutics Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ABEO / Abeona Therapeutics Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação	Ticker	Insider	Ações Reportadas	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custos	Dias para Máx
2008-02-12	ACCP	FEINBERG LARRY N	29,736	3.1500	29,736	3.1500	93,668	731
2007-06-19	ACCP	FEINBERG LARRY N	60,000	5.1700	60,000	5.1700	310,200
2007-01-22	ACCP	FEINBERG LARRY N	6,040	2.5300	6,040	2.5300	15,281
2005-12-31	ACCP	FEINBERG LARRY N	15,636	0.6500	15,636	0.6500	10,163
2005-12-31	ACCP	FEINBERG LARRY N	82,745	0.6500	82,745	0.6500	53,784
2005-12-31	ACCP	FEINBERG LARRY N	299,056	0.6500	299,056	0.6500	194,386
2005-12-31	ACCP	FEINBERG LARRY N	78,184	0.6500	78,184	0.6500	50,820
2005-02-01	ACCP	FEINBERG LARRY N	30,200	2.6900	30,200	2.6900	81,238

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

Vendas Internas ABEO / Abeona Therapeutics Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ABEO / Abeona Therapeutics Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas Preço
Reportado Ações
Ajustadas Preço
Ajustado Base de Custos Dias para
Mín Preço em
Mín Máxima Perda
Evitada ($) Máxima Perda
Evitada (%)

2008-02-12 ACCP FEINBERG LARRY N 29,736 3.1500 29,736 3.1500 93,668 731

2007-07-24 ACCP FEINBERG LARRY N 2,040 4.3500 2,040 4.3500 8,874

2007-07-23 ACCP FEINBERG LARRY N 4,000 4.3563 4,000 4.3563 17,425

2007-06-19 ACCP FEINBERG LARRY N 40,000 5.1700 40,000 5.1700 206,800

2007-06-19 ACCP FEINBERG LARRY N 20,000 5.1700 20,000 5.1700 103,400

2007-03-01 ACCP FEINBERG LARRY N 1,200 7.1250 1,200 7.1250 8,550

2007-02-28 ACCP FEINBERG LARRY N 10,000 7.1000 10,000 7.1000 71,000

2007-02-28 ACCP FEINBERG LARRY N 4,500 7.1000 4,500 7.1000 31,950

2007-02-27 ACCP FEINBERG LARRY N 300 7.0000 300 7.0000 2,100

2007-02-27 ACCP FEINBERG LARRY N 100 7.0000 100 7.0000 700

2007-02-26 ACCP FEINBERG LARRY N 19,000 7.3140 19,000 7.3140 138,966

2007-02-26 ACCP FEINBERG LARRY N 5,000 7.3140 5,000 7.3140 36,570

2007-02-26 ACCP FEINBERG LARRY N 1,000 7.3140 1,000 7.3140 7,314

2007-01-22 ACCP FEINBERG LARRY N 6,040 2.5300 6,040 2.5300 15,281

2006-09-01 ACCP FEINBERG LARRY N 1 1

2006-09-01 ACCP FEINBERG LARRY N 0 0

2006-09-01 ACCP FEINBERG LARRY N 0 0

2005-02-01 ACCP FEINBERG LARRY N 30,200 2.6900 30,200 2.6900 81,238

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

Compras Internas AWHL / Aspira Women's Health Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ABEO / Abeona Therapeutics Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas Preço
Reportado Ações
Ajustadas Preço
Ajustado Base de Custos Dias para
Máx Preço em
Máx Lucro
Máx ($) Retorno Máx (%)

2017-02-17 VRML FEINBERG LARRY N 617,731 1.4000 617,731 1.4000 864,823 304

2015-07-14 VRML FEINBERG LARRY N 510,204 1.9600 510,204 1.9600 1,000,000

2015-07-14 VRML FEINBERG LARRY N 1,839 1.9054 1,839 1.9054 3,504

2014-12-23 VRML FEINBERG LARRY N 972,222 1.4400 972,222 1.4400 1,400,000

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

Vendas Internas AWHL / Aspira Women's Health Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ABEO / Abeona Therapeutics Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas Preço
Reportado Ações
Ajustadas Preço
Ajustado Base de Custos Dias para
Mín Preço em
Mín Máxima Perda
Evitada ($) Máxima Perda
Evitada (%)

Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Oracle Partners Lp conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual Preço
da Ação Valor
da Transação Valor
Restante

2021-02-05 2021-01-26 4 MOTS Motus GI Holdings, Inc.
Common Stock S - Sale -30,000 0 -100.00 1.90 -57,000

2021-02-05 2021-01-26 4 MOTS Motus GI Holdings, Inc.
Common Stock S - Sale -29,115 105,885 -21.57 1.90 -55,417 201,542

2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock S - Sale -10,400 0 -100.00 0.55 -5,728

2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock S - Sale -47,885 0 -100.00 0.55 -26,270

2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock S - Sale -79,841 184,300 -30.23 0.55 -44,024 101,623

2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock S - Sale -435,596 278,300 -61.02 0.55 -240,188 153,455

2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock S - Sale -1,196,590 1,276,500 -48.38 0.55 -659,800 703,862

2020-06-10 2020-06-08 4 BIOL BIOLASE, INC
Common Stock S - Sale -358,744 264,141 -57.59 0.55 -198,816 146,387

2020-06-10 2020-06-08 4 BIOL BIOLASE, INC
Common Stock S - Sale -564,738 713,896 -44.17 0.55 -312,978 395,641

2020-06-10 2020-06-08 4 BIOL BIOLASE, INC
Common Stock, par value $0.001 per share ("Common Stock") S - Sale -2,479,456 2,473,090 -50.06 0.55 -1,374,115 1,370,586

2020-06-10 2020-06-08 4 VRML Aspira Women's Health Inc.
Warrants to acquire Common Stock X - Other -463,298 0 -100.00

2020-06-10 2020-06-08 4 VRML Aspira Women's Health Inc.
Common Stock X - Other 463,298 6,137,052 8.17 1.80 833,936 11,046,694

2020-06-09 2020-06-08 4 SLNO SOLENO THERAPEUTICS INC
Common Stock S - Sale -150,918 655,000 -18.73 3.40 -513,302 2,227,786

2020-06-09 2020-06-05 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share ("Common Stock") S - Sale -49,325 805,918 -5.77 3.34 -164,578 2,689,026

2019-10-31 2019-10-29 4 BIOL BIOLASE, INC
Series E Preferred Stock P - Purchase 1,843 1,843 57.50 105,972 105,972

2019-10-31 2019-10-29 4 BIOL BIOLASE, INC
Series E Preferred Stock P - Purchase 2,783 2,783 57.50 160,022 160,022

2019-10-31 2019-10-29 4 BIOL BIOLASE, INC
Series E Preferred Stock P - Purchase 12,765 12,765 57.50 733,988 733,988

2019-07-30 2019-07-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock P - Purchase 7,500 350,334 2.19 2.14 16,070 750,626

2019-07-30 2019-07-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share ("Common Stock") P - Purchase 49,569 2,665,050 1.90 2.14 106,207 5,710,136

2019-07-01 2019-07-01 4 MOTS Motus GI Holdings, Inc.
Common Stock P - Purchase 5,000 30,000 20.00 2.99 14,948 89,688

2019-07-01 2019-07-01 4 MOTS Motus GI Holdings, Inc.
Common Stock P - Purchase 35,000 135,000 35.00 3.02 105,553 407,133

2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock P - Purchase 25,000 25,000 3.00 75,000 75,000

2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock P - Purchase 100,000 100,000 3.00 300,000 300,000

2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock P - Purchase 138,698 550,698 33.66 3.00 416,094 1,652,094

2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock P - Purchase 93,566 379,566 32.72 3.00 280,698 1,138,698

2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock, par value $0.0001 per share ("Common Stock") P - Purchase 634,402 2,711,402 30.54 3.00 1,903,206 8,134,206

2019-06-27 2019-06-25 4 BIOL BIOLASE, INC
Common Stock S - Sale -227,155 438,585 -34.12 1.50 -340,732 657,878

2019-06-27 2019-06-25 4 BIOL BIOLASE, INC
Common Stock S - Sale -263,845 1,000,334 -20.87 1.50 -395,768 1,500,501

2019-06-27 2019-06-25 4 BIOL BIOLASE, INC
Common Stock, par value $0.001 per share ("Common Stock") S - Sale -509,000 3,676,046 -12.16 1.50 -763,500 5,514,069

2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock P - Purchase 13,548 342,834 4.11 1.22 16,568 419,252

2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock P - Purchase 128 329,286 0.04 1.20 154 394,979

2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock P - Purchase 20,360 855,243 2.44 1.22 24,898 1,045,877

2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock P - Purchase 192 834,883 0.02 1.20 230 1,001,442

2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock P - Purchase 95,235 2,615,481 3.78 1.22 116,463 3,198,472

2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share ("Common Stock") P - Purchase 900 2,520,246 0.04 1.20 1,080 3,023,035

2018-05-16 2018-05-15 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share P - Purchase 256 551,423 0.05 1.93 493 1,062,923

2018-05-16 2018-05-15 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share P - Purchase 1,218 1,669,541 0.07 1.93 2,348 3,218,207

2018-05-16 2018-05-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share P - Purchase 8,426 551,167 1.55 1.79 15,096 987,471

2018-05-16 2018-05-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share P - Purchase 40,100 1,668,323 2.46 1.79 71,843 2,988,967

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 4,016,283

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,605,156

2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 2,930,801

2017-12-06 2017-12-05 4 BIOL BIOLASE, INC
Common Stock P - Purchase 10,745,615 30,866,265 53.41 0.46 4,900,000 14,075,017

2017-12-06 2017-12-04 4 BIOL BIOLASE, INC
Common Stock P - Purchase 1,800,000 20,120,650 9.82 0.30 540,000 6,036,195

2017-08-31 2017-08-31 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock X - Other -583,333 0 -100.00

2017-08-31 2017-08-31 4 VRML VERMILLION, INC.
Common Stock X - Other 583,333 9,825,289 6.31 1.00 583,333 9,825,289

2017-08-30 2017-08-25 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock P - Purchase 583,333 583,333

2017-08-30 2017-08-25 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock H - Other -583,333 0 -100.00

2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock P - Purchase 1,800,535 3,144,811 133.94 0.12 225,067 393,101

2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Series D Preferred Stock C - Conversion -36,986 0 -100.00

2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Common Stock C - Conversion 3,698,600 18,320,650 25.29 1.24 4,586,264 22,717,606

2017-02-17 2017-02-17 4 VRML VERMILLION, INC.
Warrant to acquire Common Stock P - Purchase 1 0 -100.00

2017-02-17 2017-02-17 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share P - Purchase 617,731 9,825,289 6.71 1.40 864,823 13,755,405

2016-12-06 2016-12-05 4 BIOL BIOLASE, INC
Common Stock C - Conversion 46,463 14,608,464 0.32 1.85 85,957 27,025,658

2016-12-06 2016-12-02 4 BIOL BIOLASE, INC
Common Stock C - Conversion 53,537 14,562,001 0.37 1.78 95,296 25,920,362

2016-11-17 2016-11-16 4 BIOL BIOLASE, INC
Common Stock C - Conversion 33,674 14,508,464 0.23 1.71 57,583 24,809,473

2016-11-17 2016-11-15 4 BIOL BIOLASE, INC
Common Stock C - Conversion 18,514 14,478,326 0.13 1.72 31,844 24,902,721

2016-11-14 2016-11-14 4 BIOL BIOLASE, INC
Common Stock C - Conversion 33,674 14,459,812 0.23 1.61 54,215 23,280,297

2016-11-14 2016-11-11 4 BIOL BIOLASE, INC
Common Stock C - Conversion 48,513 14,426,138 0.34 1.81 87,809 26,111,310

2016-11-14 2016-11-10 4 BIOL BIOLASE, INC
Common Stock C - Conversion 42,000 14,377,625 0.29 1.81 76,020 26,023,501

2016-11-10 2016-11-09 4 BIOL BIOLASE, INC
Common Stock C - Conversion 125,000 14,335,625 0.88 1.70 212,500 24,370,562

2016-11-10 2016-11-08 4 BIOL BIOLASE, INC
Common Stock C - Conversion 2,000 14,230,625 0.01 1.52 3,040 21,630,550

2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock P - Purchase 850,797 2,194,983 63.29

2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Series C Preferred Stock C - Conversion -37,091 0 -100.00

2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Common Stock C - Conversion 3,699,100 14,228,625 35.13 1.13 4,179,983 16,078,346

2016-08-10 2016-08-08 4 BIOL BIOLASE, INC
Series C Preferred Stock P - Purchase 37,091 37,091 1.13 41,913 41,913

2016-08-10 2016-08-08 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock P - Purchase 850,797 2,194,983 63.29 0.12 106,350 274,373

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -22,659 0 -100.00 90,636.00 -2,053,721,124

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -19,050 0 -100.00 76,200.00 -1,451,610,000

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -3,950 0 -100.00 15,800.00 -62,410,000

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -492,846 0 -100.00 1,971,384.00 -971,588,718,864

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -854,377 0 -100.00 3,417,508.00 -2,919,840,232,516

2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share D - Sale to Issuer -3,090,732 0 -100.00 12,362,928.00 -38,210,497,183,296

2015-07-16 2015-07-14 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share P - Purchase 1,839 8,624,225 0.02 1.91 3,504 16,432,598

2015-07-16 2015-07-14 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share P - Purchase 510,204 8,624,225 6.29 1.96 1,000,000 16,903,481

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant J - Other 2,308,000 2,308,000

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant J - Other 3,846,000 3,846,000

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant J - Other 12,308,000 12,308,000

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share P - Purchase 2,361,342 4,928,288 91.99 0.65 1,534,872 3,203,387

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share P - Purchase 3,934,886 8,543,465 85.38 0.65 2,557,676 5,553,252

2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share P - Purchase 12,592,453 30,906,311 68.76 0.65 8,185,094 20,089,102

2014-12-29 2014-12-23 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock P - Purchase 583,333 0 -100.00

2014-12-29 2014-12-23 4 VRML VERMILLION, INC.
Common Stock, Par Value $0.001 per share P - Purchase 972,222 8,112,182 13.62 1.44 1,400,000 11,681,542

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant X - Other -652,724 0 -100.00

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant X - Other -1,171,866 0 -100.00

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant X - Other -4,656,852 0 -100.00

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 652,724 2,566,946 34.10 1.13 737,578 2,900,649

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 1,171,866 4,608,579 34.10 1.13 1,324,209 5,207,694

2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 4,656,852 18,313,858 34.10 1.13 5,262,243 20,694,660

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant J - Other 200,712 200,712

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant J - Other 360,350 360,350

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant J - Other 1,431,983 1,431,983

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant J - Other 652,724 652,724

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant J - Other 1,171,866 1,171,866

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant J - Other 4,656,852 4,656,852

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant J - Other -326,362 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant J - Other -326,362 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant J - Other -585,933 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant J - Other -585,933 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant J - Other -2,382,426 0 -100.00

2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant J - Other -2,382,426 0 -100.00

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant X - Other -326,362 0 -100.00

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant X - Other -585,933 0 -100.00

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant X - Other -2,328,426 0 -100.00

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 326,362 1,914,222 20.55 1.23 401,425 2,354,493

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 585,933 3,436,713 20.55 1.23 720,698 4,227,157

2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share X - Other 2,328,426 13,657,006 20.55 1.23 2,863,964 16,798,117

2013-12-23 2013-12-19 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock C - Conversion -4,339,980 0 -100.00

2013-12-23 2013-12-19 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share C - Conversion 4,339,980 7,139,960 155.00

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant P - Purchase 326,362 326,362 0.12 40,795 40,795

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant P - Purchase 326,362 326,362 0.12 40,795 40,795

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant P - Purchase 585,933 585,933 0.12 73,242 73,242

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant P - Purchase 585,933 585,933 0.12 73,242 73,242

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant P - Purchase 326,362 326,362 0.12 40,795 40,795

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant P - Purchase 585,933 585,933 0.12 73,242 73,242

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share P - Purchase 815,904 1,587,860 105.69 1.23 1,003,562 1,953,068

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share P - Purchase 1,464,842 2,850,780 105.69 1.23 1,801,756 3,506,459

2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share P - Purchase 5,821,064 11,328,580 105.69 1.23 7,159,909 13,934,153

2013-05-23 3 VRML VERMILLION, INC.
Common Stock, par value $0.001 2,799,980

2008-06-10 3 ACCP ACCESS PHARMACEUTICALS INC
Common Stock, par value $0.01 per share ("Common Stock") 247,651

2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants S - Sale 119,811 119,811

2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants P - Purchase 119,811 119,811

2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock S - Sale 72 72

2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock P - Purchase 72 72

2008-06-10 2008-02-12 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -29,736 296,483 -9.12 3.15 -93,668 933,921

2008-06-10 2008-02-12 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 29,736 296,483 11.15 3.15 93,668 933,921

2008-06-10 2007-11-10 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants J - Other 728,850 728,850

2008-06-10 2007-11-10 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock J - Other 437 437

2008-06-10 2007-07-24 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -2,040 296,483 -0.68 4.35 -8,874 1,289,701

2008-06-10 2007-07-23 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -4,000 298,523 -1.32 4.36 -17,425 1,300,456

2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 60,000 302,523 24.74 5.17 310,200 1,564,044

2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -20,000 302,523 -6.20 5.17 -103,400 1,564,044

2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -40,000 302,523 -11.68 5.17 -206,800 1,564,044

2008-06-10 2007-03-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -1,200 302,523 -0.40 7.12 -8,550 2,155,476

2008-06-10 2007-02-28 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -4,500 302,523 -1.47 7.10 -31,950 2,147,913

2008-06-10 2007-02-28 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -10,000 302,523 -3.20 7.10 -71,000 2,147,913

2008-06-10 2007-02-27 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -100 318,223 -0.03 7.00 -700 2,227,561

2008-06-10 2007-02-27 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -300 318,223 -0.09 7.00 -2,100 2,227,561

2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -1,000 318,623 -0.31 7.31 -7,314 2,330,409

2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -5,000 318,623 -1.55 7.31 -36,570 2,330,409

2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -19,000 318,623 -5.63 7.31 -138,966 2,330,409

2008-06-10 2007-01-22 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 6,040 343,623 1.79 2.53 15,281 869,366

2008-06-10 2007-01-22 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -6,040 343,623 -1.73 2.53 -15,281 869,366

2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -0 343,623 0.00

2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -0 343,623 0.00

2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -1 343,623 0.00

2008-06-10 2006-06-05 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock J - Other -1,374,497 343,624 -80.00

2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 78,184 1,718,121 4.77 0.65 50,820 1,116,779

2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 299,056 1,718,121 21.07 0.65 194,386 1,116,779

2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 82,745 1,718,121 5.06 0.65 53,784 1,116,779

2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock P - Purchase 15,636 1,718,121 0.92 0.65 10,163 1,116,779

2008-06-10 2005-02-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock S - Sale -30,200 1,242,500 -2.37 2.69 -81,238 3,342,325

2008-06-10 2005-02-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock, par value $0.01 per share ("Common Stock") P - Purchase 30,200 1,242,500 2.49 2.69 81,238 3,342,325

P

Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo

S

Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo

A

Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)

C

Conversão de derivativo

D

Venda ou transferência de ativos de volta para a empresa

F

Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa

G

Doação de ativos pelo ou para o insider

K

Swaps de capital e transações de hedge similares

M

Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)

V

Uma transação voluntariamente reportada no Formulário 4

J

Outro (acompanhado de uma nota explicativa descrevendo a transação)

Data de Negociação	Ticker	Insider	Ações Reportadas	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custos	Dias para Máx
2017-02-17	VRML	FEINBERG LARRY N	617,731	1.4000	617,731	1.4000	864,823	304
2015-07-14	VRML	FEINBERG LARRY N	510,204	1.9600	510,204	1.9600	1,000,000
2015-07-14	VRML	FEINBERG LARRY N	1,839	1.9054	1,839	1.9054	3,504
2014-12-23	VRML	FEINBERG LARRY N	972,222	1.4400	972,222	1.4400	1,400,000

Data do Arquivo	Data da Transação	Formulário	Ticker	Ativo	Código	Ações	Ações Restantes	Variação Percentual	Preço da Ação	Valor da Transação	Valor Restante
2021-02-05	2021-01-26	4	MOTS	Motus GI Holdings, Inc. Common Stock	S - Sale	-30,000	0	-100.00	1.90	-57,000
2021-02-05	2021-01-26	4	MOTS	Motus GI Holdings, Inc. Common Stock	S - Sale	-29,115	105,885	-21.57	1.90	-55,417	201,542
2020-06-10	2020-06-09	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-10,400	0	-100.00	0.55	-5,728
2020-06-10	2020-06-09	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-47,885	0	-100.00	0.55	-26,270
2020-06-10	2020-06-09	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-79,841	184,300	-30.23	0.55	-44,024	101,623
2020-06-10	2020-06-09	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-435,596	278,300	-61.02	0.55	-240,188	153,455
2020-06-10	2020-06-09	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-1,196,590	1,276,500	-48.38	0.55	-659,800	703,862
2020-06-10	2020-06-08	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-358,744	264,141	-57.59	0.55	-198,816	146,387
2020-06-10	2020-06-08	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-564,738	713,896	-44.17	0.55	-312,978	395,641
2020-06-10	2020-06-08	4	BIOL	BIOLASE, INC Common Stock, par value $0.001 per share ("Common Stock")	S - Sale	-2,479,456	2,473,090	-50.06	0.55	-1,374,115	1,370,586
2020-06-10	2020-06-08	4	VRML	Aspira Women's Health Inc. Warrants to acquire Common Stock	X - Other	-463,298	0	-100.00
2020-06-10	2020-06-08	4	VRML	Aspira Women's Health Inc. Common Stock	X - Other	463,298	6,137,052	8.17	1.80	833,936	11,046,694
2020-06-09	2020-06-08	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	S - Sale	-150,918	655,000	-18.73	3.40	-513,302	2,227,786
2020-06-09	2020-06-05	4	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share ("Common Stock")	S - Sale	-49,325	805,918	-5.77	3.34	-164,578	2,689,026
2019-10-31	2019-10-29	4	BIOL	BIOLASE, INC Series E Preferred Stock	P - Purchase	1,843	1,843		57.50	105,972	105,972
2019-10-31	2019-10-29	4	BIOL	BIOLASE, INC Series E Preferred Stock	P - Purchase	2,783	2,783		57.50	160,022	160,022
2019-10-31	2019-10-29	4	BIOL	BIOLASE, INC Series E Preferred Stock	P - Purchase	12,765	12,765		57.50	733,988	733,988
2019-07-30	2019-07-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	7,500	350,334	2.19	2.14	16,070	750,626
2019-07-30	2019-07-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share ("Common Stock")	P - Purchase	49,569	2,665,050	1.90	2.14	106,207	5,710,136
2019-07-01	2019-07-01	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	5,000	30,000	20.00	2.99	14,948	89,688
2019-07-01	2019-07-01	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	35,000	135,000	35.00	3.02	105,553	407,133
2019-07-01	2019-06-27	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	25,000	25,000		3.00	75,000	75,000
2019-07-01	2019-06-27	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	100,000	100,000		3.00	300,000	300,000
2019-07-01	2019-06-27	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	138,698	550,698	33.66	3.00	416,094	1,652,094
2019-07-01	2019-06-27	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	93,566	379,566	32.72	3.00	280,698	1,138,698
2019-07-01	2019-06-27	4	MOTS	Motus GI Holdings, Inc. Common Stock, par value $0.0001 per share ("Common Stock")	P - Purchase	634,402	2,711,402	30.54	3.00	1,903,206	8,134,206
2019-06-27	2019-06-25	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-227,155	438,585	-34.12	1.50	-340,732	657,878
2019-06-27	2019-06-25	4	BIOL	BIOLASE, INC Common Stock	S - Sale	-263,845	1,000,334	-20.87	1.50	-395,768	1,500,501
2019-06-27	2019-06-25	4	BIOL	BIOLASE, INC Common Stock, par value $0.001 per share ("Common Stock")	S - Sale	-509,000	3,676,046	-12.16	1.50	-763,500	5,514,069
2019-03-18	2019-03-14	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	13,548	342,834	4.11	1.22	16,568	419,252
2019-03-18	2019-03-14	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	128	329,286	0.04	1.20	154	394,979
2019-03-18	2019-03-14	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	20,360	855,243	2.44	1.22	24,898	1,045,877
2019-03-18	2019-03-14	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	192	834,883	0.02	1.20	230	1,001,442
2019-03-18	2019-03-14	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	95,235	2,615,481	3.78	1.22	116,463	3,198,472
2019-03-18	2019-03-14	4	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share ("Common Stock")	P - Purchase	900	2,520,246	0.04	1.20	1,080	3,023,035
2018-05-16	2018-05-15	4	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share	P - Purchase	256	551,423	0.05	1.93	493	1,062,923
2018-05-16	2018-05-15	4	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share	P - Purchase	1,218	1,669,541	0.07	1.93	2,348	3,218,207
2018-05-16	2018-05-14	4	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share	P - Purchase	8,426	551,167	1.55	1.79	15,096	987,471
2018-05-16	2018-05-14	4	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share	P - Purchase	40,100	1,668,323	2.46	1.79	71,843	2,988,967
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			4,016,283
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,605,156
2017-12-26		3	SLNO	SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share			2,930,801
2017-12-06	2017-12-05	4	BIOL	BIOLASE, INC Common Stock	P - Purchase	10,745,615	30,866,265	53.41	0.46	4,900,000	14,075,017
2017-12-06	2017-12-04	4	BIOL	BIOLASE, INC Common Stock	P - Purchase	1,800,000	20,120,650	9.82	0.30	540,000	6,036,195
2017-08-31	2017-08-31	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	X - Other	-583,333	0	-100.00
2017-08-31	2017-08-31	4	VRML	VERMILLION, INC. Common Stock	X - Other	583,333	9,825,289	6.31	1.00	583,333	9,825,289
2017-08-30	2017-08-25	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	P - Purchase	583,333	583,333
2017-08-30	2017-08-25	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	H - Other	-583,333	0	-100.00
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	1,800,535	3,144,811	133.94	0.12	225,067	393,101
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Series D Preferred Stock	C - Conversion	-36,986	0	-100.00
2017-07-05	2017-06-30	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	3,698,600	18,320,650	25.29	1.24	4,586,264	22,717,606
2017-02-17	2017-02-17	4	VRML	VERMILLION, INC. Warrant to acquire Common Stock	P - Purchase	1	0	-100.00
2017-02-17	2017-02-17	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	617,731	9,825,289	6.71	1.40	864,823	13,755,405
2016-12-06	2016-12-05	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	46,463	14,608,464	0.32	1.85	85,957	27,025,658
2016-12-06	2016-12-02	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	53,537	14,562,001	0.37	1.78	95,296	25,920,362
2016-11-17	2016-11-16	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	33,674	14,508,464	0.23	1.71	57,583	24,809,473
2016-11-17	2016-11-15	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	18,514	14,478,326	0.13	1.72	31,844	24,902,721
2016-11-14	2016-11-14	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	33,674	14,459,812	0.23	1.61	54,215	23,280,297
2016-11-14	2016-11-11	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	48,513	14,426,138	0.34	1.81	87,809	26,111,310
2016-11-14	2016-11-10	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	42,000	14,377,625	0.29	1.81	76,020	26,023,501
2016-11-10	2016-11-09	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	125,000	14,335,625	0.88	1.70	212,500	24,370,562
2016-11-10	2016-11-08	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	2,000	14,230,625	0.01	1.52	3,040	21,630,550
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	850,797	2,194,983	63.29
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Series C Preferred Stock	C - Conversion	-37,091	0	-100.00
2016-10-05	2016-09-30	4	BIOL	BIOLASE, INC Common Stock	C - Conversion	3,699,100	14,228,625	35.13	1.13	4,179,983	16,078,346
2016-08-10	2016-08-08	4	BIOL	BIOLASE, INC Series C Preferred Stock	P - Purchase	37,091	37,091		1.13	41,913	41,913
2016-08-10	2016-08-08	4	BIOL	BIOLASE, INC Warrants to acquire Common Stock	P - Purchase	850,797	2,194,983	63.29	0.12	106,350	274,373
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-22,659	0	-100.00	90,636.00	-2,053,721,124
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-19,050	0	-100.00	76,200.00	-1,451,610,000
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-3,950	0	-100.00	15,800.00	-62,410,000
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-492,846	0	-100.00	1,971,384.00	-971,588,718,864
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-854,377	0	-100.00	3,417,508.00	-2,919,840,232,516
2016-07-29	2016-07-27	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	D - Sale to Issuer	-3,090,732	0	-100.00	12,362,928.00	-38,210,497,183,296
2015-07-16	2015-07-14	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	1,839	8,624,225	0.02	1.91	3,504	16,432,598
2015-07-16	2015-07-14	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	P - Purchase	510,204	8,624,225	6.29	1.96	1,000,000	16,903,481
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	2,308,000	2,308,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	3,846,000	3,846,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Series E Warrant	J - Other	12,308,000	12,308,000
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	2,361,342	4,928,288	91.99	0.65	1,534,872	3,203,387
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	3,934,886	8,543,465	85.38	0.65	2,557,676	5,553,252
2015-05-14	2015-05-12	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	P - Purchase	12,592,453	30,906,311	68.76	0.65	8,185,094	20,089,102
2014-12-29	2014-12-23	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	P - Purchase	583,333	0	-100.00
2014-12-29	2014-12-23	4	VRML	VERMILLION, INC. Common Stock, Par Value $0.001 per share	P - Purchase	972,222	8,112,182	13.62	1.44	1,400,000	11,681,542
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-652,724	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-1,171,866	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	X - Other	-4,656,852	0	-100.00
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	652,724	2,566,946	34.10	1.13	737,578	2,900,649
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	1,171,866	4,608,579	34.10	1.13	1,324,209	5,207,694
2014-08-25	2014-08-25	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	4,656,852	18,313,858	34.10	1.13	5,262,243	20,694,660
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	200,712	200,712
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	360,350	360,350
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series D Warrant	J - Other	1,431,983	1,431,983
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	652,724	652,724
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	1,171,866	1,171,866
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B/C Exchange Warrant	J - Other	4,656,852	4,656,852
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-326,362	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-326,362	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-585,933	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-585,933	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series B Warrant	J - Other	-2,382,426	0	-100.00
2014-08-12	2014-08-11	4	HNSN	HANSEN MEDICAL INC Series C Warrant	J - Other	-2,382,426	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-326,362	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-585,933	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Series A Warrant	X - Other	-2,328,426	0	-100.00
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	326,362	1,914,222	20.55	1.23	401,425	2,354,493
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	585,933	3,436,713	20.55	1.23	720,698	4,227,157
2014-02-18	2014-02-14	4	HNSN	HANSEN MEDICAL INC Common Stock, par value $0.0001 per share	X - Other	2,328,426	13,657,006	20.55	1.23	2,863,964	16,798,117
2013-12-23	2013-12-19	4	VRML	VERMILLION, INC. Warrants to acquire Common Stock	C - Conversion	-4,339,980	0	-100.00
2013-12-23	2013-12-19	4	VRML	VERMILLION, INC. Common Stock, par value $0.001 per share	C - Conversion	4,339,980	7,139,960	155.00
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series A Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series C Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	326,362	326,362		0.12	40,795	40,795
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	585,933	585,933		0.12	73,242	73,242
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Series B Warrant	P - Purchase	2,328,426	2,328,426		0.12	291,053	291,053
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	815,904	1,587,860	105.69	1.23	1,003,562	1,953,068
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	1,464,842	2,850,780	105.69	1.23	1,801,756	3,506,459
2013-08-08	2013-08-08	4	HNSN	HANSEN MEDICAL INC Common Stock, par value$0.0001 per share	P - Purchase	5,821,064	11,328,580	105.69	1.23	7,159,909	13,934,153
2013-05-23		3	VRML	VERMILLION, INC. Common Stock, par value $0.001			2,799,980
2008-06-10		3	ACCP	ACCESS PHARMACEUTICALS INC Common Stock, par value $0.01 per share ("Common Stock")			247,651
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	S - Sale	119,811	119,811
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	P - Purchase	119,811	119,811
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	S - Sale	72	72
2008-06-10	2008-03-11	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	P - Purchase	72	72
2008-06-10	2008-02-12	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-29,736	296,483	-9.12	3.15	-93,668	933,921
2008-06-10	2008-02-12	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	29,736	296,483	11.15	3.15	93,668	933,921
2008-06-10	2007-11-10	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock Purchase Warrants	J - Other	728,850	728,850
2008-06-10	2007-11-10	4	ACCP	ACCESS PHARMACEUTICALS INC Series A Cumulative Convertible Preferred Stock	J - Other	437	437
2008-06-10	2007-07-24	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-2,040	296,483	-0.68	4.35	-8,874	1,289,701
2008-06-10	2007-07-23	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-4,000	298,523	-1.32	4.36	-17,425	1,300,456
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	60,000	302,523	24.74	5.17	310,200	1,564,044
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-20,000	302,523	-6.20	5.17	-103,400	1,564,044
2008-06-10	2007-06-19	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-40,000	302,523	-11.68	5.17	-206,800	1,564,044
2008-06-10	2007-03-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1,200	302,523	-0.40	7.12	-8,550	2,155,476
2008-06-10	2007-02-28	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-4,500	302,523	-1.47	7.10	-31,950	2,147,913
2008-06-10	2007-02-28	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-10,000	302,523	-3.20	7.10	-71,000	2,147,913
2008-06-10	2007-02-27	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-100	318,223	-0.03	7.00	-700	2,227,561
2008-06-10	2007-02-27	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-300	318,223	-0.09	7.00	-2,100	2,227,561
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1,000	318,623	-0.31	7.31	-7,314	2,330,409
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-5,000	318,623	-1.55	7.31	-36,570	2,330,409
2008-06-10	2007-02-26	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-19,000	318,623	-5.63	7.31	-138,966	2,330,409
2008-06-10	2007-01-22	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	6,040	343,623	1.79	2.53	15,281	869,366
2008-06-10	2007-01-22	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-6,040	343,623	-1.73	2.53	-15,281	869,366
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-0	343,623	0.00
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-0	343,623	0.00
2008-06-10	2006-09-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-1	343,623	0.00
2008-06-10	2006-06-05	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	J - Other	-1,374,497	343,624	-80.00
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	78,184	1,718,121	4.77	0.65	50,820	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	299,056	1,718,121	21.07	0.65	194,386	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	82,745	1,718,121	5.06	0.65	53,784	1,116,779
2008-06-10	2005-12-31	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	P - Purchase	15,636	1,718,121	0.92	0.65	10,163	1,116,779
2008-06-10	2005-02-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock	S - Sale	-30,200	1,242,500	-2.37	2.69	-81,238	3,342,325
2008-06-10	2005-02-01	4	ACCP	ACCESS PHARMACEUTICALS INC Common Stock, par value $0.01 per share ("Common Stock")	P - Purchase	30,200	1,242,500	2.49	2.69	81,238	3,342,325